Literature DB >> 12027071

Fenoterol inhibits superoxide anion generation by human polymorphonuclear leukocytes via beta-adrenoceptor-dependent and -independent mechanisms.

Zafar Nazir Mirza1, Masahiko Kato, Hirokazu Kimura, Atsushi Tachibana, Toru Fujiu, Masato Suzuki, Hiroyuki Mochizuki, Kenichi Tokuyama, Akihiro Morikawa.   

Abstract

BACKGROUND: Beta2-adrenoceptor agonists, used widely as bronchodilator in treating bronchial asthma, may have anti-inflammatory activity.
OBJECTIVE: We examined whether various widely prescribed beta2-adrenoceptor agonists differ in anti-inflammatory mechanisms.
METHODS: We investigated effects of these drugs on superoxide anion generation by stimulated human polymorphonuclear leukocytes in vitro using chemiluminescence.
RESULTS: At high concentrations, fenoterol significantly inhibited both N-formylmethionyl-leucyl-phenylalanine- and phorbol myristate acetate-induced superoxide generation by neutrophils. In contrast, salbutamol or procaterol partially inhibited generation with the former stimulus but not the latter. Inhibition by salbutamol or procaterol was completely reversed by either propranolol, a nonselective beta-adrenoceptor antagonist, or ICI-118551, a beta2-adrenoceptor-selective antagonist. In contrast, the effect of fenoterol at concentrations exceeding 10(-6) M against superoxide generation with the former stimulus was only partially reversed by antagonists, and the effect of high concentrations of fenoterol against generation with the latter stimulus was not reversed. No drugs scavenged superoxide at the highest concentration used (10(-5) M).
CONCLUSIONS: Fenoterol at high concentrations has an inhibitory effect on superoxide generation that includes a component not mediated via beta2-adrenoceptors. Direct inhibition at or downstream from protein kinase C may be involved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027071     DOI: 10.1016/s1081-1206(10)62388-5

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  6 in total

1.  Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions.

Authors:  A Tachibana; M Kato; H Kimura; T Fujiu; M Suzuki; A Morikawa
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

2.  Procaterol inhibits lung fibroblast migration.

Authors:  Tadashi Kohyama; Yasuhiro Yamauchi; Hajime Takizawa; Susumu Itakura; Sumiko Kamitani; Masashi Desaki; Shin Kawasaki; Takahide Nagase
Journal:  Inflammation       Date:  2009-12       Impact factor: 4.092

3.  Dissociations in the effects of β2-adrenergic receptor agonists on cAMP formation and superoxide production in human neutrophils: support for the concept of functional selectivity.

Authors:  Irena Brunskole Hummel; Michael T Reinartz; Solveig Kälble; Heike Burhenne; Frank Schwede; Armin Buschauer; Roland Seifert
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 4.  Bench-to-bedside review: beta2-Agonists and the acute respiratory distress syndrome.

Authors:  Gavin D Perkins; Daniel F McAuley; Alex Richter; David R Thickett; Fang Gao
Journal:  Crit Care       Date:  2003-12-23       Impact factor: 9.097

Review 5.  Association between β2-Adrenergic Receptor-16Arg/Gly Gene Polymorphism and Chronic Obstructive Pulmonary Disease Risk:Systematic Review and Meta-Analysis.

Authors:  Wei Wang; Ping Li; Yifei Chen; Jiong Yang
Journal:  Iran J Public Health       Date:  2014-07       Impact factor: 1.429

Review 6.  Role of arformoterol in the management of COPD.

Authors:  Paul King
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.